About Pegaspargase
Class: | Antineoplastic agent, Enzyme (L-asparaginase)
Use: | Treatment of acute lymphoblastic leukemia (ALL) as part of a multi-agent chemotherapy regimen
Adult dose: | 2,500 IU/m² administered intramuscularly or intravenously once every 14 days
Pediatric dose: | 2,500 IU/m² administered intramuscularly or intravenously once every 14 days
Side effects: | Hypersensitivity reactions, pancreatitis, hepatotoxicity, thrombosis, hyperglycemia, nausea, vomiting, fatigue
Contraindications: |
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.